Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novavax, FDA and Influenza vaccine
Novavax’s stock slides 19% after FDA puts clinical hold on COVID and flu vaccine candidates
Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its COVID-19-and-flu combination and stand-alone flu vaccine candidates, following a case of motor neuropathy in a participant in a mid-stage trial.
Novavax says FDA put hold on combination Covid-flu shot and influenza vaccine; shares plunge
The so-called clinical hold is due to a single report of nerve damage in a patient who received the combination shot in a phase two trial.
US FDA pauses Novavax's trial of combo COVID-flu shot on safety concerns
The U.S. Food and Drug Administration has put Novavax's trial of an experimental COVID-flu vaccine combination on hold after one person who received the shot reported nerve damage, the company said on Wednesday.
Opinion
5h
Opinion
Commentary: Your vaccine list should include COVID-19 update
As the COVID virus continues to evolve, experts in respiratory diseases recommend that everyone ages 6 months and older ...
10d
Novavax gets EU authorization for updated COVID vaccine targeting JN.1 strain
The European Commission authorized Novavax's updated COVID-19 vaccine targeting the JN.1 strain of coronavirus in the region, ...
2d
Novavax’s Regulatory Setback and Mid-Term Underperformance: An Analyst’s Perspective
Analyst Eric Joseph of J.P. Morgan maintained a Sell rating on Novavax (NVAX – Research Report), retaining the price target of $9.00.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Judge unseals new evidence
Preliminary cause of death
Frozen waffles recalled
Nationwide blackout in Cuba
Republicans appeal ruling
La Nina could arrive soon
Ex-MN congressman dies
NC breaks turnout record
Challenges military listing
Emergency abortion ruling
NK sending troops to RU?
Bladder cancer drug pulled
Probes near miss in Austin
Opioid suits settlement deal
‘Full Self-Driving’ probe
$4M LAPD fentanyl seizure
US charges ex-Indian spy
Antitrust ruling delayed
PG&E shuts off power
FAA opens new safety review
Musk's first Trump event
At decade-high level
To furlough 700 workers
Teen tobacco use falls
School shooting report
Nevada US Senate debate
Eases voting rules
Fire prompts evacuations
Three Americans detained
OK classroom Bible suit
Related topics
Covid
FDA
Food and Drug Administration
Feedback